![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Brent R. L. Ethical and legal implications of drug use in pregnancy. Drug Use in Pregnancy, L. Stern. ADIS Health Science Press, Sydney etc 1984; 1–11
- Lamont R. F. Drugs in pregnancy and neonatal jaundice. Drugs and Pregnancy, D. F. Hawkins. Churchill Livingstone, Edinburgh 1983; 184–203
- Ledward R. S., Hawkins D. F. Drug Treatment in Obstetrics. Chapman and Hall, London 1983; 177–188
- Minkoff H., Grunebaum A. M., Schwarz R. H., Feldman J., Cummings M., Crombleholme W., Clark L., Pringle G., McCormack W. M. Risk factors for prematurity and premature rupture of the membranes: a prospective study of the vaginal flora in pregnancy. American Journal of Obstetrics and Gynecology 1984; 150: 965–972
- Morgan I. F. D. Metronidazole treatment in pregnancy. International Journal of Gynaecology and Obstetrics 1978; 15: 501–507
- Snider D. E., Jr., Layde P. M., Johnson M. W., Lyle M. A. Treatment of tuberculosis during pregnancy. American Review of Respiratory Diseases 1980; 122: 65–79